dChan
Anonymous ID: 3683d6 May 13, 2025, 6:30 a.m. No.23028363   🗄️.is 🔗kun   >>8374

I would like a weekly update - I’m 55 and haven’t been to a doctor since 2020. I’m waiting for the ‘doctor upgrade pack’ to be installed worldwide because I have trust issues with them being Big Pharma shills

>>23028347

Anonymous ID: 3683d6 May 13, 2025, 9:09 a.m. No.23028828   🗄️.is 🔗kun   >>8838 >>8859

Full list of drugs that could be slashed under Trump's new executive order

 

Cancer Treatments (Chemotherapy & Immunotherapy taken by more than 1,230,000 patients):

 

  1. Keytruda (pembrolizumab)

 

  • Cost per dose: $10,800–$15,200

 

  • Used to treat melanoma, lung, bladder cancers, Hodgkin’s lymphoma

 

  • What it could cost under the new EO: about $4,100 (Germany), a reduction of 73 percent

 

  1. Opdivo (nivolumab)

 

  • Cost per dose: $7,500–10,500

 

  • Used to treat lung, kidney, liver, colorectal cancers

 

  • What it could cost under the new EO: $2,800 (France), a reduction of 73 percent

 

  1. Darzalex (daratumumab)

 

  • Cost per dose: $6,500

 

  • Used to treat multiple myeloma

 

  • What it could cost under the new EO: $2,900 (Netherlands), a reduction of 55 percent

 

  1. Rituxan (rituximab)

 

  • Cost per dose: $5,200–8,000

 

  • Used to treat non-Hodgkin’s lymphoma

 

  • What it could cost under the new EO: $2,400 (Belgium), a reduction of 70 percent

 

  1. Tecentriq (atezolizumab)

 

  • Cost per dose: $8,200

 

  • Used to treat bladder, lung, and breast cancers

 

  • What it could cost under the new EO: $3,500 (Germany), a reduction of 57 percent

 

  1. Herceptin (trastuzumab)

 

  • Cost per dose: $4,500

 

  • Used to treat anemia from chemotherapy

 

  • What it could cost under the new EO: $1,900 (UK), a reduction of 58 percent

 

  1. Procrit

 

  • Cost per dose: $750

 

  • Used to treat anemia

 

  • What it could cost under the new EO: $320 (Spain), a reduction of 57 percent

 

Autoimmune & Inflammatory Diseases

 

  1. Orencia (abatacept)

 

  • Cost per dose: $1,600

 

  • Used to treat rheumatoid arthritis

 

  • What it could cost under the new EO: $700, a reduction of 54 percent

 

  1. Actemra (tocilizumab)

 

  • Cost per dose: $1,200

 

  • Used to treat rheumatoid arthritis, Covd inflammation

 

  • What it could cost under the new EO: $550, a reduction of 54 percent

 

  1. Enbrel (etanercept)

 

  • Cost per dose $1,600

 

  • Used to treat psoriasis, psoriatic arthritis

 

  • EU average cost per dose: $700 (Spain)

 

  • What it could cost under the new EO: $700, a reduction of 56 percent

 

  1. Stelara (ustekinumab)

 

  • Cost per dose: $14,000

 

  • Used to treat psoriasis, Crohn’s disease

 

  • What it could cost under the new EO: $6,500, a reduction of 54 percent

 

  1. Xolair (omalizumab)

 

  • Cost per dose: $1,300

 

  • Used to treat severe asthma, chronic hives

 

  • What it could cost under the new EO: $600, a reduction of 117 percent

 

Neurological & Rare Diseases

 

  1. Tysabri (natalizumab)

 

  • Cost per dose: $7,000

 

  • Used to treat multiple sclerosis, Crohn’s

 

  • What it could cost under the new EO: $3,200 a reduction of 119 percent

 

  1. Soliris (eculizumab)

 

  • Cost per dose: $32,000

 

  • Used to treat PNH, aHUS (rare blood disorders)

 

  • What it could cost under the new EO: $18,000 (India) a reduction of 78 percent

 

Eye Diseases

 

  1. Eylea (aflibercept)

 

  • Cost per dose: $1,850

 

  • Used to treat wet AMD, diabetic retinopathy

 

  • What it could cost under the new EO: $800 (India), a reduction of 131 percent

 

  1. Lucentis (ranibizumab)

 

  • Cost per dose: $1,200

 

  • Used to treat wet AMD, macular edema

 

  • What it could cost under the new EO: $450 (France), a reduction of 167 percent

 

Supportive Care (Chemo Side Effects/Bone Health)

 

  1. Neulasta (pegfilgrastim)

 

  • Cost per dose: $6,200

 

  • Boosts white blood cells post-chemo

 

  • What it could cost under the new EO: $2,600 (Spain), a reduction of 121 percent

 

  1. Prolia (denosumab)

 

  • Cost per dose: $1,300 O

 

  • Used to treat osteoporosis (cancer-related bone loss)

 

  • What it could cost under the new EO: $600 (Italy), a reduction of 117 percent

 

Other High-Cost Therapies

 

  1. Rebif (interferon beta-1a)

 

  • Cost per dose: $3,600/month

 

  • Used to treat multiple sclerosis

 

  • What it could cost under the new EO: $1,500 (Netherlands), a reduction of 140 percent

 

  1. Nucala (mepolizumab)

 

  • Cost per dose: $4,000

 

  • Used to treat severe asthma

 

https://www.dailymail.co.uk/health/article-14704173/Full-list-drugs-slashed-Trumps-new-exec-order.html